Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 29Breast Carcinoma In Situ 4Carcinoma, Intraductal, Noninfiltrating 3Endometrial Neoplasms 2Carcinoma, Ductal, Breast 2Breast Neoplasms, Male 2Sleep Wake Disorders 1Paget's Disease, Mammary 1Gliosarcoma 1Glioblastoma 1Fatigue 1Desmoid Tumors 1Central Nervous System Neoplasms 1Carcinoma, Lobular 1Advanced, Persistent, or Recurrent Endometrial Cancer 1

Interventions

Tamoxifen 1Medroxyprogesterone Acetate 1Letrozole 1Everolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Advanced, Persistent, or Recurrent Endometrial Cancer × Tamoxifen × Clear all
NCT02228681 2024-09-19

Everolimus and Letrozole or Hormonal Therapy to Treat Endometrial Cancer

GOG Foundation

Phase 2 Completed
74 enrolled 13 charts
Gynecologic

Advanced, Persistent, or Recurrent Endometrial Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡